Skip to main content

Table 1 Demographic and medical characteristics of men with prostate cancer on androgen deprivation therapy in Toronto, Ontario, Canada, July 2015–October 2016 (N = 46)

From: RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy

Variable Mean ± SD or n (%)
Age 73.2 ± 7.3
Marital Status
 Never married 3 (6.5)
 Married/common law 39 (84.8)
 Widowed 2 (4.3)
 Divorced 2 (4.3)
Education
 Some high school 4 (8.7)
 Completed high school 4 (8.7)
 Some university/college 13 (28.3)
 Completed university/college 16 (34.8)
 Some/completed graduate school 9 (19.5)
Employment status
 Employed full−/part-time 11 (23.9)
 Retired 34 (73.9)
 Other 1 (2.2)
Ethnicity
 White 37 (80.4)
 Black 4 (8.7)
 South Asian 2 (4.3)
 Southeast Asian 1 (2.2)
 Other 2 (4.3)
Body mass index 28.0 ± 3.0
 Healthy weight 8 (17.4)
 Overweight 26 (56.5)
 Obese 12 (26.1)
Number of comorbidities
 None 4 (8.7)
 1 11 (23.9)
 2 14 (30.4)
  ≥ 3 18 (36.9)
aMost common comorbidities
 High blood pressure 27 (61.4)
 High cholesterol 19 (43.2)
 Arthritis 15 (34.1)
Smoking status
 Never smoked 23 (50.0)
 Ex-smoker 22 (47.8)
 Regular smoker 1 (2.2)
Alcohol consumption
 Never 8 (17.4)
 Less than once a month 7 (15.2)
 2–3 times a month 5 (10.9)
 Once a week 4 (8.7)
 2–3 times a week 6 (13.0)
 4–6 times a week 8 (17.4)
 Every day 8 (17.4)
Months since diagnosis 93.6 ± 71.2
Disease stage
 Localized 30 (65.2)
 Metastatic 15 (32.6)
 Unsure 1 (2.2)
Androgen deprivation therapy administration
 Continuous 29 (63.0)
 Intermittent 15 (32.6)
 Unsure 2 (4.3)
aCurrent/prior prostate cancer treatment
 Surgery 25 (54.3)
 Radiation 38 (82.6)
 Chemotherapy 3 (6.5)
Current treatment status
 Completed treatment 19 (41.3)
 Receiving treatment 27 (58.7)
Cancer disease recurrence
 Yes 16 (34.8)
 No 30 (65.2)
Current cancer disease status
 Disease-free 15 (32.6)
 Existing disease 31 (67.4)
  1. a could check more than one